These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
537 related articles for article (PubMed ID: 19651473)
21. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells. Smith CG; Kharkwal H; Wilson DW J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496 [TBL] [Abstract][Full Text] [Related]
22. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306 [TBL] [Abstract][Full Text] [Related]
23. Viral, immunologic, and clinical features of primary effusion lymphoma. Lurain K; Polizzotto MN; Aleman K; Bhutani M; Wyvill KM; Gonçalves PH; Ramaswami R; Marshall VA; Miley W; Steinberg SM; Little RF; Wilson W; Filie AC; Pittaluga S; Jaffe ES; Whitby D; Yarchoan R; Uldrick TS Blood; 2019 Apr; 133(16):1753-1761. PubMed ID: 30782610 [TBL] [Abstract][Full Text] [Related]
24. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection. Katano H Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675 [TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9 ablating viral microRNA promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus. Liang Z; Qin Z; Riker AI; Xi Y Biochem Biophys Res Commun; 2020 Dec; 533(4):1400-1405. PubMed ID: 33092788 [TBL] [Abstract][Full Text] [Related]
26. Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin β3 Levels and Is Dependent on STAT3. Rivera-Soto R; Dissinger NJ; Damania B J Virol; 2020 Feb; 94(5):. PubMed ID: 31801855 [TBL] [Abstract][Full Text] [Related]
27. Elevated IL-13 in effusions of patients with HIV and primary effusion lymphoma as compared with other Kaposi sarcoma herpesvirus-associated disorders. Ramaswami R; Lurain K; Marshall VA; Rupert A; Labo N; Cornejo-Castro E; Miley W; Wang HW; Widell A; Lindsley M; Yuan C; Stetler-Stevenson M; Filie AC; Whitby D; Ziegelbauer JM; Uldrick TS; Yarchoan R AIDS; 2021 Jan; 35(1):53-62. PubMed ID: 33273183 [TBL] [Abstract][Full Text] [Related]
28. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Dupin N; Fisher C; Kellam P; Ariad S; Tulliez M; Franck N; van Marck E; Salmon D; Gorin I; Escande JP; Weiss RA; Alitalo K; Boshoff C Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4546-51. PubMed ID: 10200299 [TBL] [Abstract][Full Text] [Related]
29. Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma. Manzano M; Günther T; Ju H; Nicholas J; Bartom ET; Grundhoff A; Gottwein E mBio; 2020 Aug; 11(4):. PubMed ID: 32843547 [TBL] [Abstract][Full Text] [Related]
31. Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies. Patel R; Lurain K; Yarchoan R; Ramaswami R Expert Rev Anti Infect Ther; 2023; 21(9):929-941. PubMed ID: 37578202 [TBL] [Abstract][Full Text] [Related]
32. Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Cai Q; Verma SC; Lu J; Robertson ES Adv Virus Res; 2010; 78():87-142. PubMed ID: 21040832 [TBL] [Abstract][Full Text] [Related]
33. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies. Kalt I; Masa SR; Sarid R Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790 [TBL] [Abstract][Full Text] [Related]
34. 18F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters. Polizzotto MN; Millo C; Uldrick TS; Aleman K; Whatley M; Wyvill KM; O'Mahony D; Marshall V; Whitby D; Maass-Moreno R; Steinberg SM; Little RF; Yarchoan R J Infect Dis; 2015 Oct; 212(8):1250-60. PubMed ID: 25828248 [TBL] [Abstract][Full Text] [Related]
35. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies. Sakakibara S; Tosato G J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154 [TBL] [Abstract][Full Text] [Related]
36. Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Burbelo PD; Issa AT; Ching KH; Wyvill KM; Little RF; Iadarola MJ; Kovacs JA; Yarchoan R J Infect Dis; 2010 Jun; 201(12):1919-22. PubMed ID: 20443737 [TBL] [Abstract][Full Text] [Related]
37. HIV-associated Kaposi sarcoma and related diseases. Gonçalves PH; Uldrick TS; Yarchoan R AIDS; 2017 Sep; 31(14):1903-1916. PubMed ID: 28609402 [TBL] [Abstract][Full Text] [Related]
38. Concomitant Kaposi sarcoma and multicentric Castleman's disease in a heart transplant recipient. Patel A; Bishburg E; Zucker M; Tsang P; Nagarakanti S; Sabnani I Heart Lung; 2014; 43(6):506-9. PubMed ID: 25169666 [TBL] [Abstract][Full Text] [Related]
39. Lymphoid disorders associated with HHV-8/KSHV infection: facts and contentions. Gaidano G; Castaños-Velez E; Biberfeld P Med Oncol; 1999 Apr; 16(1):8-12. PubMed ID: 10382936 [TBL] [Abstract][Full Text] [Related]
40. Relationship between the quantity of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood and effusion fluid samples and KSHV-associated disease. Marcelin AG; Motol J; Guihot A; Caumes E; Viard JP; Dussaix E; Cadranel J; Frances C; Carcelain G; Calvez V; Dupin N J Infect Dis; 2007 Oct; 196(8):1163-6. PubMed ID: 17955434 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]